Regulacje i polityka gospodarcza · 15/11/1995

FDA Announces Public Workshops on Biopharmaceutical Regulatory Policy Issues

The FDA is hosting two free public workshops to address regulatory policy issues in biopharmaceutical development and manufacturing, targeting small companies involved in clinical trials and product marketing approval. The workshops will cover topics such as licensing, manufacturing, and clinical trial design.